FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3817011000001107: Zindaclin 1% gel (Canute Pharma Ltd) 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2369251000001118 Zindaclin 1% gel (Canute Pharma Ltd) 30 gram en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2369261000001115 Zindaclin 1% gel (Canute Pharma Ltd) 30 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Is a Clindamycin 1% gel 30 gram true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Is pack of Zindaclin 1% gel (Canute Pharma Ltd) false Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has active ingredient Clindamycin phosphate false Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has active ingredient Clindamycin false Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has AMP Zindaclin 1% gel (Canute Pharma Ltd) true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clindamycin true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has specific active ingredient Clindamycin phosphate true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Canute Pharma Ltd) 30 gram Has basis of strength substance Clindamycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start